Which obesity index is the most useful marker for predicting hepatic steatosis in children and adolescents with obesity? A cross-sectional study using quantitative magnetic resonance imaging.

[1]  N. Méndez-Sánchez,et al.  Detangling the interrelations between MAFLD, insulin resistance, and key hormones , 2022, Hormones.

[2]  Zhihui Li,et al.  Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis , 2021, International Journal of Public Health.

[3]  Neena E Thomas-Eapen.  Childhood Obesity. , 2021, Primary care.

[4]  B. Liao,et al.  Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease , 2021, Therapeutic advances in chronic disease.

[5]  J. Schwimmer,et al.  Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease , 2021, Clinical liver disease.

[6]  Anam Bashir,et al.  Childhood Obesity as a Predictor of Coronary Artery Disease in Adults: A Literature Review , 2020, Cureus.

[7]  E. D. del Giudice,et al.  Pediatric obesity-related non-alcoholic fatty liver disease: waist-to-height ratio best anthropometrical predictor , 2020, Pediatric Research.

[8]  Geir Bjorklund,et al.  Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors. , 2020, Current medicinal chemistry.

[9]  C. Mantzoros,et al.  Adiponectin and leptin in the diagnosis and therapy of NAFLD. , 2019, Metabolism: clinical and experimental.

[10]  C. Mantzoros,et al.  Leptin trajectories from birth to mid-childhood and cardio-metabolic health in early adolescence. , 2019, Metabolism: clinical and experimental.

[11]  Hong Chen,et al.  Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model” , 2018, World journal of gastroenterology.

[12]  Kyungwon Oh,et al.  The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects , 2018, Korean journal of pediatrics.

[13]  C. Byrne,et al.  Nonalcoholic Fatty Liver Disease in Children , 2018, Seminars in Liver Disease.

[14]  Rong Yu,et al.  A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease , 2017, Lipids in Health and Disease.

[15]  Z. Younossi,et al.  Pediatric Non-Alcoholic Fatty Liver Disease , 2017, Children.

[16]  M Hassan Murad,et al.  Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. , 2017, The Journal of clinical endocrinology and metabolism.

[17]  Wenjian Song,et al.  Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis , 2017, BioMed research international.

[18]  E. Tsochatzis,et al.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.

[19]  E. Yu,et al.  Intimate association of visceral obesity with non‐alcoholic fatty liver disease in healthy Asians: A case‐control study , 2015, Journal of gastroenterology and hepatology.

[20]  C. Sirlin,et al.  Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease , 2015, Hepatology.

[21]  A. Gamst,et al.  Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. , 2015, Radiology.

[22]  M. Hofker,et al.  Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? , 2014, Biochimica et biophysica acta.

[23]  A. Feldstein,et al.  Serum Cytokeratin-18 Fragment Levels Are Useful Biomarkers for Nonalcoholic Steatohepatitis in Children , 2013, The American Journal of Gastroenterology.

[24]  S. Caprio,et al.  The Association Between Hepatic Fat Content and Liver Injury in Obese Children and Adolescents , 2013, Diabetes Care.

[25]  J. Stoker,et al.  Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children , 2013, Obesity.

[26]  J. Lavine,et al.  Advances in pediatric nonalcoholic fatty liver disease. , 2011, Pediatric clinics of North America.

[27]  J. Mandrekar.  Receiver operating characteristic curve in diagnostic test assessment. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[28]  Rocio Lopez,et al.  The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2010, Hepatology.

[29]  J. Schwimmer,et al.  Symptoms and quality of life in obese children and adolescents with non‐alcoholic fatty liver disease , 2010, Alimentary pharmacology & therapeutics.

[30]  F. Schick,et al.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.

[31]  J. Benson,et al.  The natural history of non-alcoholic fatty liver disease , 2006 .

[32]  J. Schwimmer,et al.  Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease , 2008, Circulation.

[33]  A. Feldstein,et al.  Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis , 2008, The American Journal of Gastroenterology.

[34]  Y. Murawaki,et al.  The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies , 2007, Journal of Gastroenterology.

[35]  Young-Chae Chang,et al.  Relationship between serum adiponectin and leptin concentrations and body fat distribution. , 2004, Diabetes research and clinical practice.